Evidence map›Paper›PMID 42430492›Full record

ArticleScience advances2026

Progressive intestinal tumor cell plasticity, Myc activation, and loss of Lgr5

Marika Lassila, Fatemeh Seyednasrollah, Cinzia Bessone, Maritta Räisänen, Inkeri Vuori, Davide G Berta, Johanna Aspholm, Tatiana V Petrova, Lauri A Aaltonen, Kari Alitalo and 1 more

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marika LassilaTranslational Cancer Medicine Program, Research Programs Unit, University of Helsinki, Helsinki 00014, Finland.ORCID 0009-0004-9591-2156
Fatemeh SeyednasrollahTranslational Cancer Medicine Program, Research Programs Unit, University of Helsinki, Helsinki 00014, Finland.ORCID 0009-0004-7248-1218
Cinzia BessoneTranslational Cancer Medicine Program, Research Programs Unit, University of Helsinki, Helsinki 00014, Finland.
Maritta RäisänenMedicum/Department of Medical and Clinical Genetics, University of Helsinki, Helsinki 00014, Finland.ORCID 0000-0002-2764-0433
Inkeri VuoriTranslational Cancer Medicine Program, Research Programs Unit, University of Helsinki, Helsinki 00014, Finland.
Davide G BertaMedicum/Department of Medical and Clinical Genetics, University of Helsinki, Helsinki 00014, Finland.ORCID 0000-0002-0847-998X
Johanna AspholmTranslational Cancer Medicine Program, Research Programs Unit, University of Helsinki, Helsinki 00014, Finland.ORCID 0009-0005-8999-2695
Tatiana V PetrovaDepartment of Fundamental Oncology, University of Lausanne, and Ludwig Institute for Cancer Research Lausanne, Lausanne, Switzerland.ORCID 0000-0002-0563-6521
Lauri A AaltonenMedicum/Department of Medical and Clinical Genetics, University of Helsinki, Helsinki 00014, Finland.ORCID 0000-0001-6839-4286
Kari AlitaloTranslational Cancer Medicine Program, Research Programs Unit, University of Helsinki, Helsinki 00014, Finland.ORCID 0000-0002-7331-0902
Pauliina KallioTranslational Cancer Medicine Program, Research Programs Unit, University of Helsinki, Helsinki 00014, Finland.ORCID 0000-0001-6374-6203

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasticity, the capability of tumor cells to go through phenotypic transitions, promotes colorectal cancer (CRC) progression and treatment resistance. Although plasticity is evident in advanced CRCs, little is known about plasticity in early-stage tumors and tumor stem cells. Here, we demonstrate that a plastic cell state (PCS) is present already in polyps from patients with familial adenomatous polyposis and in mouse intestinal adenomas, in which PCS is associated with

Indexed as

Cell PlasticityIntestinal NeoplasmsNeoplastic Stem CellsProto-Oncogene Proteins c-mycReceptors, G-Protein-CoupledWnt ProteinsAdenomatous Polyposis ColiAnimalsCell DifferentiationCell LineageCell ProliferationGene Expression Regulation, NeoplasticHomeodomain ProteinsHumansLymphoid Enhancer-Binding Factor 1MiceHomeodomain ProteinsLef1 protein, mouseLGR5 protein, humanLgr5 protein, mouseLymphoid Enhancer-Binding Factor 1Prospero-Related Homeobox 1 ProteinProto-Oncogene Proteins c-mycReceptors, G-Protein-CoupledTumor Suppressor ProteinsWnt Proteins

Identifiers

PMID42430492
PMCPMC13353423

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.